MedGenome aims to licence the findings to bio-technology firms and drug makers
New Delhi: Sequoia-backed MedGenome, a start-up that conducts genomics-driven research for large pharmaceutical companies, is planning to fund its own research in the area of DNA sequencing and precision medicine, with an aim to licence the findings to bio-technology firms and drug makers, a top executive said.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.